(Q46611115)

23 December 2017

title

Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex (English)

1 reference

23 December 2017

1 reference

1

1 reference

23 December 2017

author name string

Keith R Ridel

2

1 reference

23 December 2017

Floyd R Sallee

3

1 reference

23 December 2017

Jie Zhang

4

1 reference

23 December 2017

Tara D Lipps

5

1 reference

23 December 2017

Eric M Wassermann

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

23 December 2017

published in

Neuropsychopharmacology

1 reference

23 December 2017

volume

31

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

442-449

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300806

exact match

0 references

cites work

Corticocortical inhibition in human motor cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

Interaction between intracortical inhibition and facilitation in human motor cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Mechanisms influencing stimulus-response properties of the human corticospinal system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Disturbed transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Cerebral function revealed by transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Transcranial magnetic stimulation: a new investigational and treatment tool in psychiatry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Selective modulation of excitatory and inhibitory microcircuits by dopamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Subjective reactions of children to single-pulse transcranial magnetic stimulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Should transcranial magnetic stimulation research in children be considered minimal risk?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Dopaminergic inhibition of excitatory inputs onto pyramidal tract neurons in cat motor cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Methylphenidate facilitates and disinhibits the motor cortex in intact humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Effects of bromocriptine on human subjects depend on working memory capacity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Pharmacokinetics and Clinical Effectiveness of Methylphenidate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Mesencephalic dopamine neurons projecting to neocortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Effects of dextroamphetamine on cognitive performance and cortical activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Corticomotor threshold to magnetic stimulation: normal values and repeatability.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Children with comorbid attention-deficit-hyperactivity disorder and tic disorder: Evidence for additive inhibitory deficits within the motor system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Localization of dopamine D4 receptors in GABAergic neurons of the primate brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

The variability of intracortical inhibition and facilitation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Single and multiple-unit analysis of cortical stage of pyramidal tract activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Topiramate selectively decreases intracortical excitability in human motor cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Population pharmacokinetics of methylphenidate in children with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Effects of ovarian hormones on human cortical excitability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Serum and brain concentrations of methylphenidate: implications for use and abuse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Neurophysiological methods testing the psychoneural basis of attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

1 reference

7 January 2021

Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Transcranial magnetic stimulation: its current role in epilepsy research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300806

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300806

1 reference

23 December 2017

1 reference

23 December 2017